A prospective co-hort study about efficacy and safety for sorafenib treatment in patients with advanced hepatocellular carcinoma.
Phase of Trial: Phase III
Latest Information Update: 15 Nov 2016
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 15 Nov 2016 Status changed from recruiting to completed,according to the results presented at The Liver Meeting 2016: 67th Annual Meeting of the American Association for the Study of Liver Diseases.
- 07 Mar 2012 New trial record